Headlands Technologies LLC Has $1.02 Million Stake in Amedisys, Inc. (NASDAQ:AMED)

Key Points

• Headlands Technologies LLC increased its holdings in Amedisys, Inc. by 117.7%, acquiring a total of 11,041 shares valued at approximately $1.02 million by the end of the first quarter.
• Amedisys reported $1.54 EPS for the last quarter, surpassing the analysts' estimate of $1.39 and showing a 5.2% increase in revenue year-over-year, totaling $621.86 million.
• Shares of Amedisys stock rose 1.6%, with a current trading price of $100.88, following a recent rating reassessment by Royal Bank of Canada, maintaining an "outperform" rating.

Headlands Technologies LLC grew its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 117.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,041 shares of the health services provider's stock after acquiring an additional 5,969 shares during the period. Headlands Technologies LLC's holdings in Amedisys were worth $1,023,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in AMED. Pentwater Capital Management LP lifted its stake in shares of Amedisys by 178.3% in the fourth quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock worth $107,132,000 after buying an additional 756,000 shares during the last quarter. AQR Arbitrage LLC lifted its stake in shares of Amedisys by 59.1% in the fourth quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider's stock worth $42,812,000 after buying an additional 175,311 shares during the last quarter. Toronto Dominion Bank acquired a new stake in shares of Amedisys in the fourth quarter worth $15,801,000. CIBRA Capital Ltd lifted its stake in shares of Amedisys by 359.7% in the first quarter. CIBRA Capital Ltd now owns 216,775 shares of the health services provider's stock worth $20,080,000 after buying an additional 169,616 shares during the last quarter. Finally, Gotham Asset Management LLC lifted its stake in shares of Amedisys by 77.4% in the fourth quarter. Gotham Asset Management LLC now owns 246,918 shares of the health services provider's stock worth $22,418,000 after buying an additional 107,720 shares during the last quarter. 94.36% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Wall Street Zen cut shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Royal Bank Of Canada reiterated an "outperform" rating and set a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th.

Amedisys Stock Performance

NASDAQ:AMED traded down $0.06 during trading hours on Tuesday, hitting $100.91. 158,615 shares of the company traded hands, compared to its average volume of 402,224. The stock has a market capitalization of $3.32 billion, a price-to-earnings ratio of 39.27, a P/E/G ratio of 1.35 and a beta of 0.89. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $101.01. The firm has a 50-day moving average of $97.47 and a 200 day moving average of $94.52. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.26.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.15. Amedisys had a net margin of 3.56% and a return on equity of 12.91%. The company had revenue of $621.86 million during the quarter, compared to analysts' expectations of $614.61 million. During the same quarter in the prior year, the company posted $0.98 EPS. The business's revenue was up 5.2% on a year-over-year basis. On average, analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.